Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/24 19:30 | 10/28/24 | JANX | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | 2 | S | -2,496 | 49.92 | 0 | -50 | 307 | D | |||||||||||||||
10/24/24 16:15 | 9/13/24 | JANX | Health | Drug | Pharmaceutical Preparations | Lichter Jay | CA | T | 1 | S.d | -178 | 46.68 | 0 | -4 | 0 | 6,561 | D | |||||||||||||||
10/18/24 18:51 | 10/16/24 | JANX | Health | Drug | Pharmaceutical Preparations | Avalon Ventures Xi, L.P. | CA | T | 4 | S.dm | -123,251 | 46.09 | 0 | -2,674 | 9,779 | M | ||||||||||||||||
9/27/24 19:32 | 9/27/24 | JANX | Health | Drug | Pharmaceutical Preparations | Meyer Andrew Hollman | CA | O | Chief Bu | 1 | S.d | -2,298 | 45.96 | 0 | -50 | 68 | D | |||||||||||||||
9/27/24 19:31 | 9/27/24 | JANX | Health | Drug | Pharmaceutical Preparations | Diraimondo Thomas | CA | O | Chief Sc | 1 | S | -232 | 46.34 | 0 | -5 | 98 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |